MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Ovid Therapeutics Inc. Common Stock

OVID

#3214
Ovid Therapeutics Inc. Common Stock
1.63
+2.52%
Sector:
Base:
Profit Currency:
Daily Range
1.63
1.63
Year Range
0.24
2.01
Daily Change
+2.52%
Monthly Change
-10.44%
6 month change
+29.37%
Year Change
+201.85%
Previous Close
1.59
Open
1.63
Bid
Ask
Low
1.63
High
1.63
Volume
25
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. OVID
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Zacks Zacks
PTCT OVID
2026.02.20
PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates
Seeking Alpha Seeking Alpha
OVID
2026.01.27
Ovid Therapeutics: Bullish Post-PIPE With Two Differentiated CNS Moonshots
Investing Investing
OVID
2025.12.18
Ovid’s KCC2 activator shows promising safety in early trial
Investing Investing
OVID
2025.12.11
Ovid Therapeutics shareholders approve increase in authorized shares and related proposals
Investing Investing
OVID
2025.12.11
Roth/MKM initiates Ovid Therapeutics stock with Buy rating on epilepsy drug
Investing Investing
OVID
2025.12.02
Ovid Therapeutics appoints Petra Kaufmann as chief medical officer
Benzinga Benzinga
ANRO MASI OVID VVOS TATT
2025.11.17
This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Adverum Biotechnologies (NASDAQ:ADVM), Alto Neuroscience (NYSE:ANRO)
Investing Investing
OVID
2025.11.12
Ovid Therapeutics earnings missed by $0.02, revenue fell short of estimates
Zacks Zacks
OVID TWST
2025.11.12
Ovid Therapeutics (OVID) Reports Q3 Loss, Lags Revenue Estimates
Investing Investing
OVID
2025.11.12
Meg Alexander to become Ovid Therapeutics CEO as pipeline advances
Zacks Zacks
MNKD OVID
2025.11.05
MannKind (MNKD) Tops Q3 Earnings and Revenue Estimates
Zacks Zacks
ANAB OVID
2025.11.04
AnaptysBio, Inc. (ANAB) Surpasses Q3 Earnings and Revenue Estimates

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd